In the present study, suppressing HOXA3 downregulated E-cadherin and upregulated Vimentin levels, suggesting that HOXA3 knockdown increased drug resistance in NSCLC cells by inducing EMT. This evidence concerns the gene VIM and non-small cell lung carcinoma.